CA3198529A1 - Dispositifs maxillaires et mandibulaires, poste de commande - Google Patents
Dispositifs maxillaires et mandibulaires, poste de commandeInfo
- Publication number
- CA3198529A1 CA3198529A1 CA3198529A CA3198529A CA3198529A1 CA 3198529 A1 CA3198529 A1 CA 3198529A1 CA 3198529 A CA3198529 A CA 3198529A CA 3198529 A CA3198529 A CA 3198529A CA 3198529 A1 CA3198529 A1 CA 3198529A1
- Authority
- CA
- Canada
- Prior art keywords
- housing
- mandibular
- flange
- piece
- driver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000033001 locomotion Effects 0.000 claims abstract description 53
- 210000004373 mandible Anatomy 0.000 claims abstract description 47
- 210000003205 muscle Anatomy 0.000 claims description 37
- 210000001738 temporomandibular joint Anatomy 0.000 claims description 37
- 238000004891 communication Methods 0.000 claims description 23
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 19
- 229910052760 oxygen Inorganic materials 0.000 claims description 19
- 239000001301 oxygen Substances 0.000 claims description 19
- 210000003254 palate Anatomy 0.000 claims description 16
- 238000002604 ultrasonography Methods 0.000 claims description 14
- 210000004283 incisor Anatomy 0.000 claims description 10
- 206010006514 bruxism Diseases 0.000 claims description 9
- 230000000747 cardiac effect Effects 0.000 claims description 7
- 238000002592 echocardiography Methods 0.000 claims description 7
- 238000002570 electrooculography Methods 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000035487 diastolic blood pressure Effects 0.000 claims description 3
- 230000036571 hydration Effects 0.000 claims description 3
- 238000006703 hydration reaction Methods 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 230000035488 systolic blood pressure Effects 0.000 claims description 3
- 238000009423 ventilation Methods 0.000 claims description 3
- 238000002567 electromyography Methods 0.000 claims description 2
- 230000007958 sleep Effects 0.000 description 59
- 210000000214 mouth Anatomy 0.000 description 56
- 239000003814 drug Substances 0.000 description 48
- 210000002105 tongue Anatomy 0.000 description 44
- 210000001847 jaw Anatomy 0.000 description 26
- 229940079593 drug Drugs 0.000 description 21
- 206010041235 Snoring Diseases 0.000 description 17
- 238000011282 treatment Methods 0.000 description 17
- 239000008188 pellet Substances 0.000 description 15
- 230000006870 function Effects 0.000 description 12
- 238000002106 pulse oximetry Methods 0.000 description 11
- 230000036541 health Effects 0.000 description 10
- 230000009747 swallowing Effects 0.000 description 10
- 230000004913 activation Effects 0.000 description 9
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 238000002483 medication Methods 0.000 description 9
- 230000029058 respiratory gaseous exchange Effects 0.000 description 9
- 201000002859 sleep apnea Diseases 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000000537 electroencephalography Methods 0.000 description 8
- 208000001797 obstructive sleep apnea Diseases 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 238000012544 monitoring process Methods 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 210000001584 soft palate Anatomy 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229960003711 glyceryl trinitrate Drugs 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 206010003119 arrhythmia Diseases 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000000422 nocturnal effect Effects 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 210000002396 uvula Anatomy 0.000 description 4
- NYVVVBWEVRSKIU-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;n,n-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide Chemical compound OC(=O)C(O)C(O)C(O)=O.N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 NYVVVBWEVRSKIU-UHFFFAOYSA-N 0.000 description 3
- 238000010146 3D printing Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229940051374 intermezzo Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000013011 mating Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000007830 nerve conduction Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 210000002176 pterygoid muscle Anatomy 0.000 description 3
- 230000033764 rhythmic process Effects 0.000 description 3
- 208000019116 sleep disease Diseases 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 208000024693 gingival disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000018984 mastication Effects 0.000 description 2
- 238000010077 mastication Methods 0.000 description 2
- 238000013178 mathematical model Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010049244 Ankyloglossia congenital Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000027036 Hippa Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000000916 Mandibulofacial dysostosis Diseases 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000008705 Nocturnal Myoclonus Syndrome Diseases 0.000 description 1
- 208000006199 Parasomnias Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 208000012195 Reunion island Larsen syndrome Diseases 0.000 description 1
- 206010041347 Somnambulism Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000028911 Temporomandibular Joint disease Diseases 0.000 description 1
- 201000003199 Treacher Collins syndrome Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- YYAZJTUGSQOFHG-IAVNQIGZSA-N [(6s,8s,10s,11s,13s,14s,16r,17r)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate;2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]eth Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)C1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O YYAZJTUGSQOFHG-IAVNQIGZSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 229940090167 advair Drugs 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 210000004513 dentition Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000002305 electric material Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000001983 hard palate Anatomy 0.000 description 1
- 201000000615 hard palate cancer Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000001352 masseter muscle Anatomy 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000008062 neuronal firing Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000023515 periodic limb movement disease Diseases 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000002278 reconstructive surgery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000009531 respiratory rate measurement Methods 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000008667 sleep stage Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000036346 tooth eruption Effects 0.000 description 1
- 210000003901 trigeminal nerve Anatomy 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/56—Devices for preventing snoring
- A61F5/566—Intra-oral devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
- A61B5/4538—Evaluating a particular part of the muscoloskeletal system or a particular medical condition
- A61B5/4542—Evaluating the mouth, e.g. the jaw
- A61B5/4557—Evaluating bruxism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
- A61B5/4818—Sleep apnoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
- A61B5/682—Mouth, e.g., oral cavity; tongue; Lips; Teeth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0548—Oral electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3601—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/56—Devices for preventing snoring
- A61F2005/563—Anti-bruxisme
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Nursing (AREA)
- Physiology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
- Paper (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
Abstract
Dispositifs de repositionnement mandibulaire comportant une pièce maxillaire qui a un revêtement dentaire avec une collerette d'entraînement faisant saillie latéralement vers l'extérieur du côté droit à proximité d'un moule dentaire le plus arrière et/ou du côté gauche à proximité du moule dentaire le plus arrière et comportant une pièce mandibulaire qui a un revêtement dentaire doté d'une collerette saillante s'étendant vers le crâne à partir de cette dernière. Chaque collerette d'entraînement comporte un côté antérieur ayant une courbure convexe et chaque collerette saillante comporte un côté postérieur avec une courbure concave-convexe de sa base vers son point le plus crânien. La partie convexe de la courbure concave-convexe est positionnée pour venir en prise avec la courbure convexe de la collerette d'entraînement dans une position de repos. Le mouvement vers le bas de la pièce mandibulaire déplace la partie convexe du côté postérieur de la collerette saillante le long de la courbure convexe de la collerette d'entraînement, déplaçant ainsi la mandibule d'un utilisateur vers l'avant.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/098,355 US20210145630A1 (en) | 2019-11-15 | 2020-11-14 | Maxillary and mandibular devices, controller station, and methods of treating and/or diagnosing medical disorders |
| US17/098,355 | 2020-11-14 | ||
| PCT/US2021/072355 WO2022104354A1 (fr) | 2020-11-14 | 2021-11-11 | Dispositifs maxillaires et mandibulaires, poste de commande |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3198529A1 true CA3198529A1 (fr) | 2022-05-19 |
Family
ID=81601782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3198529A Pending CA3198529A1 (fr) | 2020-11-14 | 2021-11-11 | Dispositifs maxillaires et mandibulaires, poste de commande |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4243745A4 (fr) |
| AU (1) | AU2021379935A1 (fr) |
| CA (1) | CA3198529A1 (fr) |
| WO (1) | WO2022104354A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4661813A1 (fr) * | 2023-02-10 | 2025-12-17 | 3 Little Ladies, Inc. | Appareil ou dispositif buccal thérapeutique |
| US12403033B2 (en) | 2023-04-21 | 2025-09-02 | Achaemenid, Llc | Oral appliance for the treatment of sleep apnea |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1018209A5 (nl) * | 2008-07-07 | 2010-07-06 | Nelissen Jozef Frans | Inrichting voor het behandelen van nachtelijke ademhalingsproblemen. |
| US20140076332A1 (en) * | 2012-09-15 | 2014-03-20 | Kenneth Luco | Dental Appliance for Treatment of Obstructive Sleep Apnea (OSA) and Sleep Bruxism |
| CA2850988A1 (fr) * | 2013-05-03 | 2014-11-03 | Resmed Sas | Dispositif de repositionnement mandibulaire ameliore |
| US10376410B2 (en) * | 2015-05-08 | 2019-08-13 | Craig Flanagan | Automated, snore activated electro-mechanical mandibular advancement device |
| US9545332B2 (en) * | 2015-09-27 | 2017-01-17 | Kenneth Luco | Cuspid and first bi-cuspid bite retainer for sleep apnea |
| KR102052617B1 (ko) * | 2017-08-14 | 2019-12-05 | 주식회사 엘리오니 | 수면시 무호흡 코골이 방지 장치 |
-
2021
- 2021-11-11 WO PCT/US2021/072355 patent/WO2022104354A1/fr not_active Ceased
- 2021-11-11 AU AU2021379935A patent/AU2021379935A1/en active Pending
- 2021-11-11 EP EP21893076.6A patent/EP4243745A4/fr active Pending
- 2021-11-11 CA CA3198529A patent/CA3198529A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022104354A1 (fr) | 2022-05-19 |
| EP4243745A1 (fr) | 2023-09-20 |
| EP4243745A4 (fr) | 2024-10-09 |
| AU2021379935A9 (en) | 2024-09-12 |
| AU2021379935A1 (en) | 2023-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12478500B2 (en) | Maxillary devices, controller station, and methods of treating and/or diagnosing medical disorders | |
| US12376987B2 (en) | Dynamic mandibular and lingual repositioning devices, controller station, and methods of treating and/or diagnosing medical disorders | |
| US20250288454A1 (en) | Maxillary and mandibular devices that prevent disengagement therebetween, controller station, and methods of treating and/or diagnosing medical disorders | |
| US20210145630A1 (en) | Maxillary and mandibular devices, controller station, and methods of treating and/or diagnosing medical disorders | |
| US20130109932A1 (en) | Systems and methods for pulmonary monitoring and treatment | |
| US11786177B2 (en) | Oral appliance for the treatment of sleep apnea | |
| CA3198529A1 (fr) | Dispositifs maxillaires et mandibulaires, poste de commande | |
| US11819449B2 (en) | Maxillary and mandibular devices that increase the smallest concentric airway cross-sectional area of a user for improvements during physical activities | |
| AU2020378954B2 (en) | Intra-oral electroencephalography device and method | |
| CN212650976U (zh) | 一种可调式下颌前移侧卧止鼾装置 | |
| EP4362865A1 (fr) | Dispositifs maxillaires et mandibulaires qui augmentent la plus petite surface de section transversale concentrique des voies respiratoires d'un utilisateur pour des améliorations pendant les activités physiques | |
| US12485036B2 (en) | Maxillary and mandibular devices that increase the smallest concentric airway cross-sectional area of a user for improvements during physical activities | |
| US20250090367A1 (en) | Methods and systems to track and guide improvement in health and fitness biometrics |